We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
GSK plc | NYSE:GSK | NYSE | Depository Receipt |
Price Change | % Change | Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.78 | 1.83% | 43.35 | 43.515 | 42.75 | 42.92 | 6,320,454 | 01:00:00 |
Resolution
|
Total votes for(1)(2)
|
%
|
Total votes against(2)
|
%
|
Total votes cast
|
Votes withheld(3)
|
|
1
|
Receive and adopt the 2021 Annual Report
|
3,524,582,633
|
99.01
|
35,137,552
|
0.99
|
3,559,720,185
|
11,843,164
|
2
|
Approve the Annual report on remuneration
|
3,240,737,115
|
91.05
|
318,510,405
|
8.95
|
3,559,247,520
|
12,317,062
|
3
|
Approve the Remuneration Policy
|
2,197,755,545
|
61.76
|
1,360,515,540
|
38.24
|
3,558,271,085
|
13,294,793
|
4
|
Election of Dr Anne Beal
|
3,546,443,179
|
99.55
|
16,055,842
|
0.45
|
3,562,499,021
|
9,042,781
|
5
|
Election of Dr Harry Dietz
|
3,545,845,271
|
99.54
|
16,469,238
|
0.46
|
3,562,314,509
|
9,224,475
|
6
|
Re-election of Sir Jonathan Symonds
|
3,482,374,837
|
97.76
|
79,898,313
|
2.24
|
3,562,273,150
|
9,274,730
|
7
|
Re-election of Dame Emma Walmsley
|
3,555,195,651
|
99.79
|
7,564,971
|
0.21
|
3,562,760,622
|
8,806,465
|
8
|
Re-election of Charles Bancroft
|
3,503,934,446
|
98.36
|
58,393,472
|
1.64
|
3,562,327,918
|
9,214,474
|
9
|
Re-election of Vindi Banga
|
3,483,288,426
|
97.79
|
78,881,291
|
2.21
|
3,562,169,717
|
9,373,841
|
10
|
Re-election of Dr Hal Barron
|
3,546,018,185
|
99.54
|
16,347,031
|
0.46
|
3,562,365,216
|
9,173,855
|
11
|
Re-election of Dr Vivienne Cox
|
3,531,865,048
|
99.14
|
30,474,324
|
0.86
|
3,562,339,372
|
9,204,548
|
12
|
Re-election of Lynn Elsenhans
|
3,476,281,291
|
97.58
|
86,142,909
|
2.42
|
3,562,424,200
|
9,118,541
|
13
|
Re-election of Dr Laurie Glimcher
|
3,556,622,114
|
99.84
|
5,547,225
|
0.16
|
3,562,169,339
|
9,375,696
|
14
|
Re-election of Dr Jesse Goodman
|
3,555,655,121
|
99.82
|
6,515,409
|
0.18
|
3,562,170,530
|
9,367,820
|
15
|
Re-election of Iain Mackay
|
3,551,784,186
|
99.71
|
10,432,989
|
0.29
|
3,562,217,175
|
9,333,434
|
16
|
Re-election of Urs Rohner
|
3,410,175,068
|
95.74
|
151,806,419
|
4.26
|
3,561,981,487
|
9,561,680
|
17
|
Re-appointment of the auditor
|
3,557,280,686
|
99.84
|
5,797,033
|
0.16
|
3,563,077,719
|
8,481,780
|
18
|
Remuneration of the auditor
|
3,555,233,064
|
99.86
|
5,000,395
|
0.14
|
3,560,233,459
|
11,338,880
|
19
|
Authority for the company to make donations to political
organisations and incur political expenditure
|
3,493,409,287
|
98.64
|
48,161,797
|
1.36
|
3,541,571,084
|
30,003,446
|
20
|
Authority to allot shares
|
3,430,993,149
|
96.35
|
130,127,471
|
3.65
|
3,561,120,620
|
10,593,875
|
21
|
Disapplication of pre-emption rights - general
power(4)
|
3,460,375,320
|
97.24
|
98,220,644
|
2.76
|
3,558,595,964
|
12,963,416
|
22
|
Disapplication of pre-emption rights - in connection with an
acquisition or specified capital investment(4)
|
3,404,168,390
|
95.65
|
154,942,194
|
4.35
|
3,559,110,584
|
12,448,092
|
23
|
Authority for the company to purchase its own
shares(4)
|
3,517,497,794
|
98.79
|
43,085,674
|
1.21
|
3,560,583,468
|
10,990,502
|
24
|
Exemption from statement of senior statutory auditor's
name
|
3,523,554,816
|
99.59
|
14,359,955
|
0.41
|
3,537,914,771
|
33,655,391
|
25
|
Authority for reduced notice of a general meeting other than an
AGM(4)
|
3,331,432,180
|
93.62
|
227,176,994
|
6.38
|
3,558,609,174
|
12,950,914
|
26
|
Approve the Share Save Plan 2022
|
3,508,449,940
|
98.62
|
49,235,709
|
1.38
|
3,557,685,649
|
13,896,262
|
27
|
Approve the Share Reward Plan 2022
|
3,516,666,377
|
98.86
|
40,690,090
|
1.14
|
3,557,356,467
|
14,160,284
|
28
|
Approve the adoption of new Articles of
Association(4)
|
3,549,030,121
|
99.80
|
6,964,097
|
0.20
|
3,555,994,218
|
15,501,889
|
|
GSK's
Twenty second
AGM
(Hybrid meeting)
(2022)
|
GSK's
Twenty first
AGM
(Virtual meeting)
(2021)
|
Issued share capital (excluding Treasury Shares)
|
5,083,974,547
|
5,031,444,276
|
Total votes cast and votes withheld lodged as a % of GSK's issued
share capital (excluding Treasury Shares)
|
70.25%
|
70.11%
|
Total shareholder population
|
89,764
|
100,906
|
Total number of proxies lodged
|
5,343
|
6,089
|
Number of shareholders in attendance
|
93 in person
68 participated virtually
|
142 participated virtually
|
% of shareholders who lodged proxies
|
5.95%
|
6.03%
|
|
GlaxoSmithKline plc
|
|
(Registrant)
|
|
|
Date: May
04, 2022
|
|
|
|
|
By:/s/ VICTORIA
WHYTE
--------------------------
|
|
|
|
Victoria Whyte
|
|
Authorised
Signatory for and on
|
|
behalf
of GlaxoSmithKline plc
|
1 Year GSK Chart |
1 Month GSK Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions